---
title: "300254.SZ (300254.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300254.SZ/news.md"
symbol: "300254.SZ"
name: "300254.SZ"
parent: "https://longbridge.com/en/quote/300254.SZ.md"
datetime: "2026-05-21T01:49:57.966Z"
locales:
  - [en](https://longbridge.com/en/quote/300254.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300254.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300254.SZ/news.md)
---

# 300254.SZ (300254.SZ) — Related News

### [](https://longbridge.com/en/news/286527433.md)
*2026-05-15T07:54:16.000Z*
> The National Healthcare Security Administration issued implementation opinions on reforming and improving the supply gua

### [](https://longbridge.com/en/news/285295879.md)
*2026-05-06T01:53:13.000Z*
> The A-share innovative drug sector has fluctuated and strengthened, with TONGHUA GOLDEN-HORSE hitting the daily limit, O

### [The concept of generic drugs fluctuates and rises, Huasun hits the limit up](https://longbridge.com/en/news/284679324.md)
*2026-04-30T02:25:14.000Z*
> The concept of generic drugs is fluctuating upwards, with Huasun hitting the daily limit, NUCIEN PHARMA rising over 16%,

### [C&Y Pharmaceutical: Net profit of 3.3423 million yuan in the first quarter of 2026, a year-on-year decrease of 67.83%](https://longbridge.com/en/news/284204466.md)
*2026-04-27T11:23:29.000Z*
> C&Y Pharmaceutical announced that its revenue for the first quarter of 2026 was 174 million yuan, a year-on-year decreas

### [C&Y Pharmaceutical plans to acquire the remaining equity of its controlling subsidiary Nantong Hengjia for 140 million yuan](https://longbridge.com/en/news/279038235.md)
*2026-03-13T11:53:02.000Z*
> C&Y Pharmaceutical plans to acquire a 34% stake in Nantong Hengjia Pharmaceutical for 140 million yuan, with the acquire

### [The capital double-edged sword of the leading smoking cessation drug: veterans reduce holdings and withdraw, while the company increases its stake in subsidiaries through bottom-fishing](https://longbridge.com/en/news/277152047.md)
*2026-02-27T06:37:17.000Z*
> C&Y Pharmaceutical recently conducted a series of capital operations, including the equity unfreezing of the largest sha

### [C&Y Pharmaceutical successfully acquired 20% equity in C&Y Hailisheng](https://longbridge.com/en/news/276873228.md)
*2026-02-25T10:51:03.000Z*
> C&Y Pharmaceutical announced that the company, in conjunction with Zhoushan Ronghao Trading Co., Ltd., jointly bid for 4

### [C&Y Pharmaceutical: Shareholder Weng Zhanguo has reduced his holdings by 2.54%](https://longbridge.com/en/news/276717211.md)
*2026-02-24T10:23:09.000Z*
> C&Y Pharmaceutical announced that shareholder Weng Zhanguo has completed the reduction plan, with a total reduction of 6

### [C&Y Pharmaceutical: The shares held by the largest shareholder Zhao Qun have been judicially frozen](https://longbridge.com/en/news/275436265.md)
*2026-02-10T09:48:50.000Z*
> C&Y Pharmaceutical announced that the shares held by its largest shareholder Zhao Qun, who holds more than 5% of the sha